Buys
Open market- Shares
- +87,000
- Avg price
- $0.5481
- Total value
- +$47,681
Brent Pfeiffenberger - President and CEO, Director at Century Therapeutics, Inc.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- IPSC on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Brent Pfeiffenberger in Century Therapeutics, Inc.
Sells
Open market- Shares
- -32,456
- Avg price
- $0.4540
- Total value
- -$14,735
Net
Past year- Shares
- +54,544
- Share %
- 46%
- Total value
- +$32,946
Reported holdings for Brent Pfeiffenberger in Century Therapeutics, Inc.
Form 4 holding
President and CEO, Director
Century Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,633,839
- Estimated value
- $8,902,905
- Report date
- 04 Sep 2026
- Price
- $2.45
- Ownership
- Direct
Form 4 holding
President and CEO, Director
Century Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 945,000
- Estimated value
- Report date
- 02 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Brent Pfeiffenberger in Century Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.